Insights from the 2024 WHO Global Tuberculosis Report - More Comprehensive Action, Innovation, and Investments required for achieving WHO End TB goals

Delia Goletti¹, Graeme Meintjes², Bruno B Andrade³, Alimuddin Zumla⁴, Shui Shan Lee⁵

Affiliations

¹ Translational Research Unit, National Institute for Infectious Diseases "Lazzaro Spallanzani"- Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy. Electronic address: delia.goletti@inmi.it.
² Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom; Department of Medicine and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
³ Laboratory of Clinical and Translational Research, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil; The BRIGHT lab, Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Institute, Salvador, Brazil.
⁴ Center for Clinical Microbiology, Division of Infection and Immunity, University College London, and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, United Kingdom.
⁵ International Society for Infectious Diseases; S.H Ho Research Centre for Infectious Diseases, The Chinese University of Hong Kong, Hong Kong, China.

PMID: 39631498
DOI: 10.1016/j.ijid.2024.107325

Free article

Editorial

Insights from the 2024 WHO Global Tuberculosis Report - More Comprehensive Action, Innovation, and Investments required for achieving WHO End TB goals

Delia Goletti et al. Int J Infect Dis. 2025 Jan.

Free article

. 2025 Jan:150:107325.

doi: 10.1016/j.ijid.2024.107325. Epub 2024 Dec 2.

Authors

Delia Goletti¹, Graeme Meintjes², Bruno B Andrade³, Alimuddin Zumla⁴, Shui Shan Lee⁵

Affiliations

¹ Translational Research Unit, National Institute for Infectious Diseases "Lazzaro Spallanzani"- Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy. Electronic address: delia.goletti@inmi.it.
² Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom; Department of Medicine and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
³ Laboratory of Clinical and Translational Research, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil; The BRIGHT lab, Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Institute, Salvador, Brazil.
⁴ Center for Clinical Microbiology, Division of Infection and Immunity, University College London, and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, United Kingdom.
⁵ International Society for Infectious Diseases; S.H Ho Research Centre for Infectious Diseases, The Chinese University of Hong Kong, Hong Kong, China.

PMID: 39631498
DOI: 10.1016/j.ijid.2024.107325

No abstract available

Keywords: Diabetes; Innovation; Investments; TB-HIV coinfection; Tuberculosis; WHO tuberculosis report.

PubMed Disclaimer

Conflict of interest statement

Declarations of competing interest All authors declare no conflicts of interest.

Cited by

Prevalence and Clinical Implications of Pyrazinamide Resistance in Newly Diagnosed TB Patients in Uganda.
Ndawula C, Petra NP, Wasswa FB, Bazira J. Ndawula C, et al. Infect Drug Resist. 2025 Mar 29;18:1629-1635. doi: 10.2147/IDR.S491770. eCollection 2025. Infect Drug Resist. 2025. PMID: 40177169 Free PMC article.
Tuberculosis and Impact of COVID-19 on Spread of Epidemics in Kazakhstan.
Bekshin Z, Askarov A, Abduraimov Y, Rsaliyev A, Bissenova G, Amirkhanova N, Nurbekova Z, Temirbekova A. Bekshin Z, et al. Pathogens. 2025 Jun 4;14(6):559. doi: 10.3390/pathogens14060559. Pathogens. 2025. PMID: 40559567 Free PMC article.
Determinants of weight gain among adult tuberculosis patients on dots during intensive phase in Wonago Ethiopia, unmatched case control study.
Eyob L, Ali H, Adisu Y, Tesfaye A. Eyob L, et al. Sci Rep. 2025 Apr 12;15(1):12556. doi: 10.1038/s41598-025-97265-z. Sci Rep. 2025. PMID: 40221519 Free PMC article.
Risk factors for the progression from pulmonary tuberculosis to spinal tuberculosis: a logistic regression analysis.
Xue D, Chen X, Shao L, Liu Q, Chen J, Su Y, Zhang C, Chen Z, Su M, Wu Z, Yang Y, Lin X. Xue D, et al. J Orthop Surg Res. 2025 Apr 28;20(1):422. doi: 10.1186/s13018-025-05848-3. J Orthop Surg Res. 2025. PMID: 40296147 Free PMC article.
Machine learning-based approach for identification of new resistance associated mutations from whole genome sequences of Mycobacterium tuberculosis.
Pal A, Mohanty D. Pal A, et al. Bioinform Adv. 2025 Mar 11;5(1):vbaf050. doi: 10.1093/bioadv/vbaf050. eCollection 2025. Bioinform Adv. 2025. PMID: 40125545 Free PMC article.

See all "Cited by" articles

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Insights from the 2024 WHO Global Tuberculosis Report - More Comprehensive Action, Innovation, and Investments required for achieving WHO End TB goals

Affiliations

Insights from the 2024 WHO Global Tuberculosis Report - More Comprehensive Action, Innovation, and Investments required for achieving WHO End TB goals

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

Publication types

LinkOut - more resources

Full Text Sources

Conflict of interest statement

Similar articles

Cited by

Publication types

Related information

LinkOut - more resources

Full Text Sources